Pulmonary mucormycosis in an adolescent female with type 1 diabetes mellitus

Spellberg, 2005, Novel perspectives on mucormycosis: pathophysiology, presentation, and management, Clin Microbiol Rev, 18, 556, 10.1128/CMR.18.3.556-569.2005 McCrory, 2014, Disseminated mucormycosis in an adolescent with newly diagnosed diabetes mellitus, Pediatr Infect Dis J, 33, 1094, 10.1097/INF.0000000000000383 Rammaert, 2012, Diabetes and mucormycosis: a complex interplay, Diabetes Metab, 38, 193, 10.1016/j.diabet.2012.01.002 Petrikkos, 2012, Epidemiology and clinical manifestations of mucormycosis, Clin Infect Dis, 54, S23, 10.1093/cid/cir866 Mohammadi, 2012, Pulmonary mucormycosis in patients with diabetic ketoacidosis: a case report and review of literature, Tuberk Toraks, 60, 66, 10.5578/tt.2464 Ibrahim, 2012, Pathogenesis of mucormycosis, Clin Infect Dis, 54, S16, 10.1093/cid/cir865 Artis, 1982, A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability, Diabetes, 31, 1109, 10.2337/diacare.31.12.1109 Waldorf, 1984, Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus, J Clin Invest, 74, 150, 10.1172/JCI111395 Francis, 2018, Mucormycosis in children: review and recommendations for management, J Pediatric Infect Dis Soc, 7, 159, 10.1093/jpids/pix107 Lee, 1999, Pulmonary mucormycosis: the last 30 years, Arch Intern Med, 159, 1301, 10.1001/archinte.159.12.1301 Tedder, 1994, Pulmonary mucormycosis: results of medical and surgical therapy, Ann Thorac Surg, 57, 1044, 10.1016/0003-4975(94)90243-7